They additionally measured the plasma concentrations of plasminogen inhibitor-1 (PAI-1) and described a decrease of PAI-1 during CaD treatment, which contributes to the therapeutic effect of CaD. The gene discussed is SERPINE1; the disease is coronary artery disorder.